Related Experiment Video

Updated: Mar 14, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

The Systemic Management of Advanced Melanoma in 2016

Markus V Heppt1, Cecilia Dietrich, Saskia A Graf

  • 1Department of Dermatology and Allergy, Munich University Hospital (LMU), Munich, Germany.

Oncology Research and Treatment
|October 7, 2016
PubMed

Insights

Novel melanoma treatments, including BRAF/MEK inhibitors and immune checkpoint blockade (CTLA-4, PD-1), show promise. Combinations may improve efficacy and reduce toxicity for advanced skin cancer patients.

Area of Science:

  • Oncology
  • Dermatology
  • Immunology

Background:

  • Melanoma is a prevalent skin cancer known for metastasis.
  • Current treatments like tyrosine kinase inhibitors and immune checkpoint blockade have advanced care for advanced disease.
  • Therapeutic resistance necessitates novel strategies and drug combinations.

Purpose of the Study:

  • To offer a concise, current overview of melanoma clinical management.
  • To review the current clinical trial landscape in melanoma.
  • To summarize key studies on BRAF/MEK inhibitors and CTLA-4/PD-1 blockade.

Main Methods:

  • Literature review of pertinent studies on targeted therapies and immunotherapies.
  • Summary of clinical trial data for melanoma treatments.
  • Analysis of combination strategies and future therapeutic approaches.

Main Results:

  • BRAF/MEK inhibitors and immune checkpoint blockade demonstrate significant antitumor activity.
  • Combination therapies show enhanced efficacy compared to single-agent treatments.
  • Ongoing trials explore novel combinations for improved outcomes.

Conclusions:

  • Targeted therapies and immunotherapies have transformed melanoma treatment.
  • Combination strategies offer potential for greater efficacy and reduced toxicity.
  • Future research focuses on optimizing treatment combinations for advanced melanoma.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K